Welcome to Pangaea insights
Our collective intelligence provides an unrivalled breadth and depth of knowledge.
Pangaea’s ongoing relationships with key industry stakeholders facilitate continuous updates and dissemination of relevant market intelligence. Check back often for new posts!
Navigating while innovating: Considerations for launching in a risk-averse environment
August 21, 2020
Sometimes the new normal is simply dealing with a new level of systematic complexity that arises as the health economy and population grows, and we grapple with an ever-expanding landscape of health system needs that are as complex as they are diverse.
Pangaea Express: Impact of the recent Federal Court decision on PMPRB Guidelines
July 9, 2020
On July 8, the PMPRB updated its website to include its views on the recent Federal Court decision pertaining to the amendments to the Patented Medicines Regulations and their impact on the Guidelines.
Join our team
June 22, 2020
Join our team: Pangaea is seeking a part-time / independent consultant to support our trade team as a Trade Manager.
A Year In Review for R2D2
June 3, 2020
Overall, there are 14 projects under the R2D2 initiative that can be bucketed into four categories. Read more.
Pangaea Express: Vendor Credentialing and COVID-19
June 2, 2020
It will be critical for companies to be aware of external policies to find the right balance of criteria for re-entry into clinics & hospitals to ensure a safe and productive interaction for the benefit of Canadian patients.
Pangaea Express: Amendments to Pricing Regulations delayed to January 1, 2021
May 29, 2020
Pangaea confirms the amendments to the Patented Medicines Regulations to take effect July 1, 2020, will be implemented January 1, 2021.
Best Practices for Working Virtually
April 3, 2020
As the home office environment is new to many in this industry, we thought we would share some best practices for working virtually.
Pangaea Express: PMPRB To Make Significant Changes
April 2, 2020
The PMPRB plans to publish revised draft Guidelines this spring, that will have only a limited time-frame for feedback before being finalized.
Pangaea Express: Bill C-13 Amendments to Patent Act and Food and Drugs Act
March 26, 2020
On March 25, Bill C-13, the COVID-19 Emergency Response Act, received Royal Assent that includes amendments to both the Patent Act and the Food and Drugs Act to ensure the availability of drugs and medical devices.
Pangaea Express: Canada Ratifies USMCA
March 17, 2020
On Friday, March 13, the House of Commons and the Senate approved the new USMCA within hours of each other.